Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OVARIO: Niraparib + Bevacizumab Maintenance in Advanced Ovarian Cancer
NCT03326193Phase 2Completed
- Start
- Dec 2017
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of niraparib in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC). Started Dec 2017; status: completed.
02
Drugs
niraparib
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT03326193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03326193.